InspireMD Operating Cycle from 2010 to 2025

NSPR Stock  USD 2.44  0.01  0.41%   
InspireMD Operating Cycle yearly trend continues to be relatively stable with very little volatility. Operating Cycle is likely to grow to 327.33 this year. During the period from 2010 to 2025, InspireMD Operating Cycle destribution of quarterly values had range of 282 from its regression line and mean deviation of  77.95. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
287.84065045
Current Value
327.33
Quarterly Volatility
90.69221819
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 194.1 K, Interest Expense of 23.9 K or Selling General Administrative of 8.6 M, as well as many indicators such as Price To Sales Ratio of 14.95, Dividend Yield of 0.0 or PTB Ratio of 3.21. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
  
Build AI portfolio with InspireMD Stock
Check out the analysis of InspireMD Correlation against competitors.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

Latest InspireMD's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of InspireMD over the last few years. It is InspireMD's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InspireMD's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

InspireMD Operating Cycle Regression Statistics

Arithmetic Mean306.71
Geometric Mean294.26
Coefficient Of Variation29.57
Mean Deviation77.95
Median319.02
Standard Deviation90.69
Sample Variance8,225
Range282
R-Value(0.43)
Mean Square Error7,178
R-Squared0.19
Significance0.1
Slope(8.20)
Total Sum of Squares123,376

InspireMD Operating Cycle History

2025 327.33
2024 287.84
2023 319.02
2022 233.97
2021 224.31
2020 353.82
2019 247.6

About InspireMD Financial Statements

InspireMD shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although InspireMD investors may analyze each financial statement separately, they are all interrelated. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses on on InspireMD's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 287.84  327.33 

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.